165 related articles for article (PubMed ID: 11350610)
1. Malignant phyllodes tumor of the breast with expression of osteonectin and vinculin.
Kuroda N; Sugimoto T; Ueda S; Takahashi T; Moriki T; Sonobe H; Miyazaki E; Hayashi Y; Toi M; Hiroi M; Enzan H
Pathol Int; 2001 Apr; 51(4):277-82. PubMed ID: 11350610
[TBL] [Abstract][Full Text] [Related]
2. Malignant phyllodes tumor of the breast with liposarcomatous differentiation and intraductal hyperplasia.
Ayadi-Kaddour A; Zeddini A; Braham E; Ismail O; Mlika M; Guelmami K; El Mezni F
Breast Dis; 2015; 35(1):59-62. PubMed ID: 25061020
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of pleomorphic liposarcomatous differentiation in malignant phyllodes tumor of the breast: A case report.
Zhou P; Zhang Q; Zhu J; Li P
Pathol Res Pract; 2021 Aug; 224():153489. PubMed ID: 34091389
[TBL] [Abstract][Full Text] [Related]
4. Well-differentiated liposarcoma of the breast arising in a background of malignant phyllodes tumor in a pregnant woman: A rare case report and review of literature.
Narla SL; Stephen P; Kurian A; Annapurneswari S
Indian J Pathol Microbiol; 2018; 61(4):577-579. PubMed ID: 30303154
[TBL] [Abstract][Full Text] [Related]
5. Malignant phyllodes tumor with liposarcomatous differentiation: Diagnosed on cytology.
Kuppusamy DA; Jinkala S; Thambiraj P; Stephen N; Gochhait D; Siddaraju N; Dharanipragada K
Diagn Cytopathol; 2021 Jun; 49(6):E226-E230. PubMed ID: 33378115
[TBL] [Abstract][Full Text] [Related]
6. Heterologous Liposarcomatous Differentiation in Malignant Phyllodes Tumor is Histologically Similar but Immunohistochemically and Molecularly Distinct from Well-differentiated Liposarcoma of Soft Tissue.
Inyang A; Thomas DG; Jorns J
Breast J; 2016 May; 22(3):282-6. PubMed ID: 26843318
[TBL] [Abstract][Full Text] [Related]
7. Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.
Lin JJ; Huang CS; Yu J; Liao GS; Lien HC; Hung JT; Lin RJ; Chou FP; Yeh KT; Yu AL
Breast Cancer Res; 2014 Mar; 16(2):R29. PubMed ID: 24670249
[TBL] [Abstract][Full Text] [Related]
8. The coexistence of invasive ductal carcinoma and malignant phyllodes tumor with liposarcomatous and chondrosarcomatous differentiation in the same breast in a post-osteosarcoma case.
Kefeli M; Yildiz L; Akpolat I; Balci P; Ozen N
Pathol Res Pract; 2008; 204(12):919-23. PubMed ID: 18757140
[TBL] [Abstract][Full Text] [Related]
9. [Malignant phyllodes tumor with differentiation to liposarcoma. A report of a case and bibliographic review].
Argáez Cimé NL; Gutiérrez Vega P; López Cruz J
Ginecol Obstet Mex; 2005 Mar; 73(3):145-50. PubMed ID: 21961353
[TBL] [Abstract][Full Text] [Related]
10. Malignant phyllodes tumor with pleomorphic liposarcomatous stroma diagnosed by fine needle aspiration cytology: a case report.
Vera-Alvarez J; Marigil-Gómez M; Abascal-Agorreta M; García-Prats MD; López-López JI; Pérez-Ruiz J
Acta Cytol; 2002; 46(1):50-6. PubMed ID: 11843559
[TBL] [Abstract][Full Text] [Related]
11. CD10, actin, and vimentin expression in breast phyllodes tumors correlates with tumor grades of the WHO grading system.
Tsai WC; Jin JS; Yu JC; Sheu LF
Int J Surg Pathol; 2006 Apr; 14(2):127-31. PubMed ID: 16703173
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
Liu SY; Joseph NM; Ravindranathan A; Stohr BA; Greenland NY; Vohra P; Hosfield E; Yeh I; Talevich E; Onodera C; Van Ziffle JA; Grenert JP; Bastian BC; Chen YY; Krings G
Mod Pathol; 2016 Sep; 29(9):1012-27. PubMed ID: 27255162
[TBL] [Abstract][Full Text] [Related]
13. Rare case of biphasic tumor of the breast with prominent CD34-positive spindle cells.
Hayashi M; Tamura G; Matsumoto O; Motoyama T
Pathol Int; 2001 Sep; 51(9):713-7. PubMed ID: 11696175
[TBL] [Abstract][Full Text] [Related]
14. Malignant Phyllodes tumor in a young female: A Case Report.
Anand P; Sarin N; Butti AK; Singh S
Gulf J Oncolog; 2018 May; 1(27):64-69. PubMed ID: 30145554
[TBL] [Abstract][Full Text] [Related]
15. A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.
Cimino-Mathews A; Hicks JL; Sharma R; Vang R; Illei PB; De Marzo A; Emens LA; Argani P
Hum Pathol; 2013 Nov; 44(11):2494-500. PubMed ID: 23916291
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation.
Nie Y; Chen J; Huang D; Yao Y; Chen J; Ding L; Zeng J; Su S; Chao X; Su F; Yao H; Hu H; Song E
Cancer Res; 2017 Jul; 77(13):3605-3618. PubMed ID: 28512246
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
[TBL] [Abstract][Full Text] [Related]
18. miR-21 induces myofibroblast differentiation and promotes the malignant progression of breast phyllodes tumors.
Gong C; Nie Y; Qu S; Liao JY; Cui X; Yao H; Zeng Y; Su F; Song E; Liu Q
Cancer Res; 2014 Aug; 74(16):4341-52. PubMed ID: 24980553
[TBL] [Abstract][Full Text] [Related]
19. Fine needle aspiration cytology of malignant phyllodes tumor with liposarcomatous stroma of the breast. A case report.
Lee WY; Cheng L; Chang TW
Acta Cytol; 1998; 42(2):391-5. PubMed ID: 9568143
[TBL] [Abstract][Full Text] [Related]
20. Malignant phyllodes tumor with liposarcomatous components: a case report with cytological presentation.
Satou T; Matsunami N; Fujiki C; Tanaka K; Hayashi Y; Hashimoto S
Diagn Cytopathol; 2000 Jun; 22(6):364-9. PubMed ID: 10820530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
